Restless Legs Syndrome: A Complete Guide to Causes, Treatment, and Living Well

Condition Guide

Restless Legs Syndrome: A Complete Guide to Causes, Treatment, and Living Well

If you have ever lain in bed exhausted, only to be driven half-mad by a deep, crawling urge to move your legs that eases the moment you get up and walk — and returns the instant you lie back down — you already know the central cruelty of restless legs syndrome. It strikes precisely when you are trying to rest, sabotaging the sleep you need most. For a long time it was dismissed as a quirk or a nervous habit. It is neither. RLS, also called Willis-Ekbom disease, is a recognised neurological sensorimotor disorder, and a surprisingly common one ^[1].

The Health Field Guide · written for StormItEdited by the StormIt Health Desk

Restless legs syndrome is genuinely neurological, often profoundly disruptive to sleep, and frequently misunderstood — and, importantly, very treatable once the right cause is found. This guide walks calmly through what RLS is, the iron-and-dopamine science behind it, the treatment landscape that changed substantially in 2024, and where to find trustworthy help.

How this was written: an evidence synthesis for general readers, every claim tagged by how strong the evidence behind it is and tied to the numbered sources at the end. This is education, not medical advice — and never a reason to start, stop, or change a medication on your own. Pending clinician review prior to a future update; verify any concern with a qualified healthcare professional.

This guide is comprehensive on purpose. It walks through what RLS actually is and how it's diagnosed, the underlying biology (which is genuinely interesting and points directly to treatment), what causes and worsens it, the full treatment landscape including a major 2024 shift in expert guidance, the non-drug and complementary options with honest evidence grading, and a curated set of resources and support communities. Every medical claim is graded by how strong the evidence behind it is.

How to read the evidence tags

EstablishedWell-documented in clinical literature and reflected in current guidelines. A recognised, reproducible finding.

SuggestiveReal evidence exists, but it is partial, smaller-scale, or still debated. A reasonable option, not a certainty.

AnecdotalWidely reported by patients but not established in research. Worth knowing, not authoritative.

Section 1

What RLS is — and what it feels like

Restless legs syndrome is a neurological disorder defined by an overwhelming urge to move the legs, usually accompanied by uncomfortable sensations, that appears or worsens at rest and is relieved by movement ^[1]. People describe the sensation in strikingly varied ways: crawling, creeping, pulling, throbbing, aching, itching deep inside the leg, or an electric, fizzing restlessness that defies easy description. It is usually felt deep in the legs rather than on the skin, and most often in the calves, though it can involve the thighs, feet, and sometimes the arms ^[2].

It is common. Global estimates put the overall prevalence at around 7% of adults, with clinically significant RLS — symptoms at least twice a week causing meaningful distress — affecting roughly 1.5–2.7% ^[3][4]. It is more common in women and becomes more frequent with age ^[3]. Many people live with it for years before learning it has a name and a treatment.

The reason it matters beyond the discomfort itself is sleep. Because symptoms peak in the evening and at night, RLS is fundamentally a sleep-wrecking condition — and chronic poor sleep cascades into fatigue, low mood, impaired concentration, and reduced quality of life ^[2]. RLS is also frequently accompanied by periodic limb movements during sleep: repetitive, involuntary leg jerks that further fragment rest ^[4].

Section 2

How RLS is diagnosed

There is no blood test or scan that diagnoses RLS itself. It is a clinical diagnosis, made when a person's history meets five essential criteria established by the International Restless Legs Syndrome Study Group. A handy memory aid for the core features is URGE ^[2][5]:

Although RLS itself is diagnosed clinically, doctors typically order blood tests — especially iron studies (ferritin, transferrin saturation), and often kidney function and other labs — not to confirm RLS, but to find treatable underlying causes and rule out mimics ^[2][6]. Iron studies in particular are central, for reasons the next section makes clear. A sleep study is not usually needed to diagnose RLS, though it may be used if another sleep disorder is suspected ^[2].

Section 3

The science: iron and dopamine

Understanding the biology of RLS is genuinely useful, because it explains why the treatments that work, work — and why one popular class of drugs fell out of favour. Two intertwined systems are central: brain iron and dopamine ^[7].

Brain iron deficiency

This is the pivotal insight, and it is counterintuitive. Studies using brain imaging and autopsy tissue have consistently found reduced iron in specific brain regions of people with RLS — even when the iron level in their blood is completely normal ^[7][8]. Iron can be low where it matters — in the brain — while looking fine on a routine blood count. This is why iron status is so important in RLS, and why the thresholds used are higher than for ordinary anaemia. Established

The dopamine connection

Iron is a necessary building block for the brain's dopamine system, which helps produce smooth, controlled movement. In RLS, the same regions that show low iron also show a disturbed dopamine state ^[8]. This dopamine link explains why drugs that boost dopamine were, for years, the front-line treatment — and, as we'll see, why long-term use of those same drugs can paradoxically make RLS worse over time ^[8]. Established that both systems are involved; the precise mechanism connecting them is still being worked out.

There is also a clear genetic component — RLS often runs in families, and specific gene variants (such as BTBD9 and MEIS1) are associated with it — which is why a family history is a meaningful clue ^[8].

Iron can be low where it matters — in the brain — while looking perfectly normal on a routine blood test. That single fact reshapes how RLS is treated.

Section 4

Causes and what makes RLS worse

RLS comes in two broad forms. Primary RLS is idiopathic — no external cause — and often hereditary, frequently starting earlier in life. Secondary RLS arises from an identifiable condition and can sometimes be resolved by treating that condition ^[1]. The common drivers of secondary RLS are worth knowing because several are treatable.

Section 5

Treatment: what changed in 2024

This is the section where outdated advice is most common, because the standard of care genuinely shifted. The American Academy of Sleep Medicine posted its updated clinical practice guideline online in September 2024 and published it in Journal of Clinical Sleep Medicine on January 1, 2025, significantly changing first-line treatment for RLS — so guidance written even a few years ago may now be out of date ^[13][14]. Here is the current shape of treatment.

Before / after

2012 -> 2024: what changed

The practical shift is simple: dopamine agonists moved down, alpha-2-delta ligands moved up, and iron correction became even more central.

Treatment area	Older 2012-era pattern	2024 guidance	What to ask
Dopamine agonists	Pramipexole, ropinirole, and rotigotine were commonly treated as standard first-line long-term options.	The updated guideline recommends against standard long-term use because of augmentation and impulse-control risks ^[13][16].	If you take one, ask about augmentation and do not stop suddenly.
Alpha-2-delta ligands	Used, but often behind dopamine drugs in the usual treatment conversation.	Gabapentin enacarbil, gabapentin, and pregabalin receive strong recommendations as preferred medication options ^[13][15].	Ask whether this class fits your sleep, pain, kidney function, fall-risk, and side-effect profile.
Iron / IV iron	Iron mattered, but many patients were told their ferritin was "normal" by anemia standards.	Iron assessment is foundational; IV ferric carboxymaltose is strongly recommended when ferritin is below 100 mcg/L or TSAT below 20% ^[13][14].	Ask for ferritin and TSAT, and confirm the RLS-specific threshold your clinician is using.

“

3. Dopamine agonists: no longer recommended as standard long-term treatment

This is the headline change. Drugs like pramipexole, ropinirole, and rotigotine were first-line in the 2012 guidance. The 2024 guideline recommends against their standard long-term use, because of augmentation — a well-documented phenomenon in which the medication, over time, paradoxically makes RLS worse: symptoms grow more intense, start earlier in the day, and spread to other body parts ^[13][16]. The committee concluded that the long-term augmentation risk can outweigh the short-term symptom benefit for standard long-term use. These drugs also carry a risk of impulse-control problems ^[13][16]. Established

If you take one of these: do not stop suddenly — but do ask your doctor to review your treatment in light of the updated guidance

Section 6

Non-drug and complementary options

Many people, especially with milder RLS, get meaningful relief from non-drug measures — sometimes enough to avoid medication entirely. The evidence varies in strength, so here it is graded honestly.

A unifying caution: complementary approaches are best treated as additions to proper assessment, not replacements for it. The single highest-value step in RLS — checking iron the right way — is something only testing can guide.

Section 7

Living well with RLS

Alongside medical treatment, day-to-day habits make a real difference, mostly by protecting sleep and avoiding triggers. Common, sensible measures include keeping a regular sleep schedule and good sleep environment; moderating or cutting caffeine, alcohol, and nicotine, which frequently worsen symptoms; building in light activity and stretching during long periods of sitting; and reviewing medications with a doctor to spot any that aggravate RLS ^[12]. Keeping a simple symptom-and-trigger diary can help you and your clinician spot patterns — which foods, medications, or activities precede bad nights.

It also helps to know the condition is chronic for many people but genuinely manageable. The combination of correcting underlying causes (especially iron), using the right medication when needed, avoiding aggravators, and protecting sleep allows most people to bring RLS under meaningful control ^[10].

Section 8

When to see a doctor

RLS is rarely an emergency, but it is consistently under-diagnosed, so the main message is the opposite of alarm: if leg restlessness is disrupting your sleep or quality of life, it is worth a proper evaluation rather than years of quiet suffering.

Printable kit

Download the RLS doctor-visit kit

A one-page appointment prep sheet with a seven-night symptom-and-trigger diary, the iron studies to ask about, and a medication/supplement list you can bring to the visit.

RLS doctor-visit kit PDFSymptom diary, ferritin/TSAT note, medication list, and appointment questions.Plain-text kitThe same doctor-visit prep in a copyable hosted text file.

When you go, it helps to come prepared: note when symptoms occur, what they feel like, what relieves them, your family history, and a full list of medications and supplements. Asking specifically for iron studies (ferritin and transferrin saturation) is reasonable, given how central iron is to both diagnosis and treatment ^[13].

Resources

Resources and support

The following are reputable starting points for reliable information and community. Organisations and links can change; verify details on each site, and bring anything you read to your own clinician.

Authoritative organizations & medical information

Restless Legs Syndrome Foundation — Patient organization · flagship. The leading non-profit dedicated to RLS. Offers patient education, a healthcare-provider directory, the latest treatment information, research updates, and a Get Support hub with local and virtual support groups. The first place most patients should look.

International Restless Legs Syndrome Study Group (IRLSSG) — Research & clinical standards. The scientific body behind the diagnostic criteria and severity scales used worldwide. A good source for the underlying clinical framework and the published treatment guidelines.

NINDS (U.S. National Institute of Neurological Disorders and Stroke) — Government health information. Clear, authoritative, plain-language overview of RLS causes, diagnosis, and treatment from the U.S. federal neuroscience agency, with current research directions.

Cleveland Clinic — Restless Legs Syndrome — Clinical reference. A reliable, regularly updated clinical overview covering symptoms, causes, diagnosis, and treatment options in accessible language.

AASM / JCSM clinical practice guideline — Primary treatment guideline. The professional guideline that reshaped RLS treatment (iron and alpha-2-delta ligands up; dopamine agonists down). The AASM's plain-language announcement is also useful context, but the JCSM article is the authority.

Sleep health context

Sleep Foundation — Restless Legs Syndrome — Sleep education. Approachable, well-referenced articles connecting RLS to broader sleep health, with practical self-management guidance.

Peer communities (use thoughtfully — see note below)

r/RestlessLegs (Reddit) — Online community. An active peer community where people share experiences, triggers, and what has and hasn't worked for them. Strong on lived experience and emotional support; not a source of medical advice.

RLS Foundation Support Groups & Facebook communities — Support groups. The RLS Foundation coordinates volunteer-led local and virtual support groups, and there are numerous Facebook groups (search "Restless Legs Syndrome") where patients connect. The Foundation-affiliated options are the most reliably moderated starting point.

“

A note on using communities wisely

Peer communities are genuinely valuable for RLS. They reduce isolation, validate a condition that's often dismissed, and frequently prompt people to push for proper iron testing or a treatment review they wouldn't have known to ask for. Many people first learned their dopamine medication might be causing augmentation from a fellow patient, not a doctor.

They also carry the usual risks: confident misinformation, supplement marketing, and one person's success generalised into universal advice. RLS is variable enough between individuals that what transformed someone else's nights may do nothing for yours. Treat these spaces as encouragement and shared experience — and take specific medical decisions, especially anything involving iron dosing or changing medications, to a clinician. An anecdote is a reason to ask a question, never an answer to it.

Sources

References

"Restless legs syndrome," AMBOSS (Willis-Ekbom disease; primary vs secondary; associations and aggravating drugs), 2026. [Online]. Available: amboss.com
Cleveland Clinic, "Restless Legs Syndrome (RLS): Causes, Symptoms & Treatment." [Online]. Available: my.clevelandclinic.org
"The global and regional prevalence of restless legs syndrome among adults: A systematic review and modelling analysis," PMC, NIH (global prevalence ~7.12% of adults). [Online]. Available: ncbi.nlm.nih.gov/pmc/PMC11156251
"The Management of Restless Legs Syndrome: An Updated Algorithm," Mayo Clinic Proceedings, 2021 (clinically significant RLS prevalence 1.5–2.7%; periodic limb movements). [Online]. Available: mayoclinicproceedings.org
"Restless Legs Syndrome," The Neurology Center (IRLSSG diagnostic criteria). [Online]. Available: neurologycenter.com
R. P. Allen et al., "Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children," Sleep Med, vol. 41, pp. 27-44, Jan. 2018. doi: 10.1016/j.sleep.2017.11.1126. Accessed: Jul. 9, 2026. [Online]. Available: https://doi.org/10.1016/j.sleep.2017.11.1126
"Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome," PubMed (decreased brain iron; relative dopamine excess), 2017. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/28236139. Accessed: Jul. 9, 2026. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/28236139
NINDS, "Restless Legs Syndrome" (low brain iron; basal ganglia/dopamine; genetics; aggravating medications). [Online]. Available: ninds.nih.gov
"Current updates in Restless Legs Syndrome: A pragmatic review," Annals of Movement Disorders, 2024 (pregnancy and ESRD; non-pharmacological strategies; iron thresholds). [Online]. Available: journals.lww.com
Pacific Neuroscience Institute, "Restless Legs Syndrome" (associated conditions; management overview), 2026. [Online]. Available: pacificneuroscienceinstitute.org
"Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management," Frontiers in Aging Neuroscience (aggravating drug classes). [Online]. Available: ncbi.nlm.nih.gov/pmc/PMC5454050
"The Management of Restless Legs Syndrome: An Updated Algorithm" (RLS Foundation Scientific & Medical Advisory Board; lifestyle, triggers, complementary therapies). [Online]. Available: rls.org
J. W. Winkelman et al., "Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline," J Clin Sleep Med, vol. 21, no. 1, pp. 137-152, Jan. 1, 2025. doi: 10.5664/jcsm.11390. Accessed: Jul. 9, 2026. [Online]. Available: https://doi.org/10.5664/jcsm.11390
AASM, "New guideline provides treatment recommendations for RLS," Nov. 13, 2024 (accepted paper posted Sept. 26, 2024; JCSM issue Jan. 1, 2025). [Online]. Available: https://aasm.org/new-guideline-provides-treatment-recommendations-for-restless-legs-syndrome/. Accessed: Jul. 9, 2026. [Online]. Available: https://aasm.org/new-guideline-provides-treatment-recommendations-for-restless-legs-syndrome/
J. W. Winkelman et al., "Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment," J Clin Sleep Med, vol. 21, no. 1, pp. 153-199, Jan. 1, 2025. doi: 10.5664/jcsm.11392. Accessed: Jul. 9, 2026. [Online]. Available: https://doi.org/10.5664/jcsm.11392
D. Garcia-Borreguero et al., "Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation," Sleep Med, vol. 21, pp. 1-11, May 2016. doi: 10.1016/j.sleep.2016.01.017. Accessed: Jul. 9, 2026. [Online]. Available: https://doi.org/10.1016/j.sleep.2016.01.017
J. D. Charlesworth et al., "Bilateral high-frequency noninvasive peroneal nerve stimulation evokes tonic leg muscle activation for sleep-compatible reduction of restless legs syndrome symptoms," J Clin Sleep Med, vol. 19, no. 7, pp. 1199-1209, July 2023. doi: 10.5664/jcsm.10536. Accessed: Jul. 9, 2026. [Online]. Available: https://doi.org/10.5664/jcsm.10536
"Pneumatic Compression Devices for Treatment of Restless Legs Syndrome," CHEST (randomised, sham-controlled evidence of benefit). [Online]. Available: journal.chestnet.org

Restless Legs Syndrome: A Complete Guide to Causes, Treatment, and Living Well